Thankfully, it seems President Joe Biden heard it. With First Lady Jill Biden next to him, the president established the "first ever" White House Initiative on Women's Health Research. It will bring together experts from the entire administration, the private sector, research institutions, and philanthropic organizations "to drive innovation in women's health and close research gaps."

Those gaps are present at the most fundamental level: women have been historically under-represented in clinical trials, and research focused on women's health has been vastly underfunded. I'm not talking about reproductive organs: what we call "women's health" goes well beyond that.

Women have been left out of, or underrepresented in, a huge range of studies. Consider the health conditions that are more common in women, such as Alzheimer's disease, rheumatoid arthritis, and even adenocarcinoma. Clinical presentation in many conditions is different for women as well, especially with heart disease. For too long and for too many women, these differences — and lack of targeted studies — have led to misdiagnoses, mistreatment, and poor health outcomes.

I want this White House initiative to transform how women's health research is funded and conducted. That can only happen by starting with the basics — understanding that men and women are different at the cellular level. About a third of the genes that people carry are expressed differently in men and women. As a result, clinical presentation, treatment options, and health outcomes often differ.

It is why Erica Ollmann Saphire, PhD, MBA, president and CEO of the La Jolla Institute for Immunology, said, "Studying sex-based differences in a systematic manner will help uncover the causes and allow for treatments that are in tune with biology."

My expertise comes from cardiology, where not taking this approach meant we didn't learn until the mid-1980s that women were dying from heart disease at higher rates than men. I'd been taught it was a "man's disease." In fact, over 60 million women in the U.S. (44%) are living with some form of heart disease, the leading cause of death for women and men. The president's task force will have to contend with another tough fact: women represent only about one in five participants in cardiovascular disease clinical trials.